US Physical Therapy Inc expected to post earnings of 57 cents a share - Earnings Preview

US Physical Therapy

26/02/2024 23:02

* US Physical Therapy Inc  USPH.N   USPH.K  is expected
to show a
rise in quarterly revenue when it reports  results on February
28 for the period ending December 31 2023
    * The Houston Texas-based  company is expected to report a
6.4% increase in revenue to $150.27 million from $141.18 million
a year ago, according to the mean estimate from 6 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for US Physical Therapy Inc
is for
earnings of 57 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for US Physical
Therapy Inc is $108.00​, above​ its last closing price
of $100.87. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  0.64        0.62       0.62      Met     0.5
 Jun. 30 2023  0.75        0.75       0.76      Beat    1.6
 Mar. 31 2023  0.55        0.55       0.59      Beat    8.3​
 Dec. 31 2022  0.58        0.57       0.58      Beat    1.8
 ​​Sep.        0.58        0.56       0.58      Beat    3.2
 30 2022                                                
 Jun. 30 2022  0.95        0.95       0.90      Missed  -4.9​
 Mar. 31 2022  0.63        0.63       0.65      Beat    2.8
 Dec. 31 2021  0.69        0.69       0.72      Beat    4.7
 This summary was machine generated February 26 at 23:02 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)